Article Details
Retrieved on: 2024-12-21 18:10:03
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses FDA approval of Zepbound, a GLP-1 agonist like tirzepatide, for treating obstructive sleep apnea in obese adults, indicating potential links between obesity, diabetes, and sleep disorders in its treatment strategies.
Article found on: www.npr.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here